Success Story: NIW Approval for a Cancer Data Science Expert in over 7 Months without RFE
Client’s Testimonial:
"It was truly a pleasure working with you."
On May 23rd, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Research Technician in the Field of Cancer Data Science (Approval Notice).
General Field: Cancer Data Science
Position at the Time of Case Filing: Research Technician
Country of Origin: Pakistan
State of Residence at the Time of Filing: Arizona
Approval Notice Date: May 23rd, 2026
Processing Time: 7 months, 16 days
Case Summary:
Our firm is pleased to share that an EB-2 NIW (National Interest Waiver) petition approval for a research technician in cancer data science was obtained in over 7 months without RFE. With over 32,000 successful cases to our name, we are proud that our expert team's thorough preparation secured a well-deserved approval for this exceptionally talented researcher.
Client Background and Proposed Endeavor
Holding an M.B.B.S., this researcher brings specialized expertise in artificial intelligence applications, statistical modeling, and evidence synthesis for oncology. The proposed endeavor is to continue developing novel methods for clinical guideline development to synthesize evidence and use AI to improve cancer treatment paradigms, optimize care, address disparities, foster inclusivity, and enhance clinical decision-making.
National Significance of the Research
We emphasized that this research carries significant importance and has far-reaching implications for the United States. The novel AI-driven methodologies and living systematic review frameworks developed here directly address critical inequities in cancer care, ensuring that clinicians have access to the most current, evidence-based treatment recommendations for all patient populations. Fellow experts in the field provided additional insight into the national importance of this endeavor, confirming that this work is crucial for improving public health outcomes and reducing the economic burden of cancer disparities in the U.S.
Impressive Credentials and Achievements
To further strengthen the case, we highlighted exceptional credentials:
- Publications: An impressive portfolio of 7 peer-reviewed journal articles, 1 peer-reviewed conference article, 30 abstracts, and 1 preprint.
- Citations: The published body of work has been cited 83 times.
Recommendation Letters
Two recommendation letters from leading experts in oncology and cancer data science were submitted in support of this petition. The expert remarked:
"The broad acknowledgment of [Client]’s contributions reinforces her expertise and the pivotal role she plays in advancing equitable, effective cancer care, further solidifying her standing as a leading figure in cancer data science."
Case Outcome
This researcher's pioneering contributions to AI-driven evidence synthesis, living systematic reviews, and equitable cancer care position them to make meaningful and lasting contributions to U.S. public health and oncological leadership for years to come. We are honored to have supported this journey and extend our sincere best wishes for continued success in both research and clinical pursuits.